Frontage Laboratories Recognized as “Fastest Growing Company” by INC Magazine
Exton, P.A. – August 22, 2014 – Frontage today announced recognition by INC Magazine in the INC 5000. For the second time in three years, Frontage earned a spot on the magazine’s thirty-third annual compilation of America’s fastest-growing privately-held companies. Qualifying organizations must demonstrate consistent year-on-year revenue growth and future potential success. In the past three years, the company has achieved nearly 50% revenue growth and added close to 100 new positions. Among companies listed in the greater Philadelphia area, Frontage ranked sixteenth position for new jobs creation.
“Once again, we are honored that Frontage Labs is included on this prestigious list of high-growth organizations,” said Song Li, Founder and CEO of Frontage. “This honor affirms the efforts of our hard-working and dedicated staff who routinely help clients solve technical challenges and enable them to advance promising investigational medicines to the next stage of product development.”
A contract research organization, Frontage supports biopharmaceutical organizations through full service offerings– including bioanalysis, preclinical and clinical studies, analytical testing and product development support– spanning discovery stages through late-stage clinical trials. The company also provides CMC product development, bioequivalence and analytical services to generic and consumer health pharmaceutical companies to support Abbreviated NDA and 505.b.2 application submissions.
With a 12-year history, eight state-of-the art research facilities and more than 300 professionals in the US and China, Frontage has enabled both brand and generic pharmaceutical companies of all sizes to advance hundreds of molecules through clinical development and commercial launch in global markets. For more information, visit www.frontagelab.com.